BioPharmaTrend
News
All Topics
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
  • NeuroTech
  • Interviews
  • Business Intelligence
  • Case Studies
Intelligence
  • Business Intelligence
  • Case Studies
  • Lab
  • Membership
About
  • At a Glance
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Newsletter
Login/Join
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
  • NeuroTech

Biopharma Insights


Seven RNA Biotech Companies To Watch …

Seven RNA Biotech Companies To Watch in 2026

June 16, 2024   by Andrii Buvailo     Articles
For many years the focus of therapeutic developments and scientific research was directed at the genome and proteins. Yet, there …
Continue ›››
AI and CRISPR—converging revolutions in biomedicine?

AI and CRISPR—converging revolutions in biomedicine?

Oct. 13, 2025   by Louise von Stechow     Business Intelligence
Since the discovery of its mechanism in 2012, CRISPR-based gene editing has turned from basic discovery into a bioengineering tool …
Continue ›››
15 Useful Mobile Apps For Life …

15 Useful Mobile Apps For Life Scientists

Sept. 1, 2018   by Anastasiia Rohozianska     Articles
Nowadays, mobile devices are ubiquitous with an estimated number of smartphones and tablet PCs to exceed two billion globally. The …
Continue ›››
Five AI-driven Drug Discovery Companies Enabling …

Five AI-driven Drug Discovery Companies Enabling Precision Oncology

June 29, 2023   by Irina Bilous     Articles
Artificial Intelligence (AI) is steadily making its presence felt across various sectors, including the pharmaceutical industry. Among the multiple applications …
Continue ›››
How Big Pharma Adopts AI To …

How Big Pharma Adopts AI To Boost Drug Discovery

July 6, 2023   by Andrii Buvailo     Articles
(Last updated: October 2025) Since 1950, when Alan Turing introduced the concept of 'thinking machines', artificial intelligence has steadily advanced—from …
Continue ›››
How Lantern Pharma's AI-driven Approach Enables …

How Lantern Pharma's AI-driven Approach Enables Precision Oncology

June 13, 2023   by Andrii Buvailo     Articles
Sponsored by Lantern Pharma
Lantern Pharma’s AI-driven drug discovery platform RADR® enables value creation across multiple dimensions of the oncology drug development process: from …
Continue ›››
12 Emerging Companies to Watch in …

12 Emerging Companies to Watch in Neurotech Space

Aug. 4, 2024   by Andrii Buvailo, PhD     Articles
Brain-computer interface (BCI) technologies are rapidly becoming the spotlight of the neurotech industry, with Neuralink at the forefront. Recently, Neuralink …
Continue ›››

The Pivotal Role of AI in Clinical Trials: From Digital Twins to Synthetic Control Arms

Oct. 11, 2024   by BiopharmaTrend     Articles
Artificial Intelligence (AI) is redefining the clinical trial process, offering solutions that address long-standing challenges in drug development. The traditional …
Continue ›››
5 AI-Powered Companies Transforming the Future …

5 AI-Powered Companies Transforming the Future of Fertility Care

June 28, 2023   by Dana Sokolova     Articles
The field of fertility treatments is experiencing a surge in demand, fueled by several significant factors. A shift towards starting …
Continue ›››
17 Companies Pioneering AI Foundation Models …

17 Companies Pioneering AI Foundation Models in Pharma and Biotech

June 19, 2024   by Andrii Buvailo     Business Intelligence
Foundation models represent a relatively new paradigm in artificial intelligence (AI), revolutionizing how machine learning models are developed and deployed. Foundation …
Continue ›››
Why AI Needs to Be at …

Why AI Needs to Be at the Center of mRNA Design

Sept. 30, 2025   by Davide De Lucrezia     Business Intelligence
One of the biggest hurdles in mRNA development is the in vitro to in vivo gap; results that look strong …
Continue ›››
Phesi Reports GLP-1 Trials Now Span …

Phesi Reports GLP-1 Trials Now Span 100+ Diseases

Sept. 15, 2025   by Anastasiia Rohozianska     Business Intelligence
Phesi has published an analysis showing that GLP-1 drugs are now being tested across more than 100 diseases, extending well …
Continue ›››
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
#advertisement
Pharma Complience Management: A UK/EU Guide

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Newsletter
  • Business Intelligence
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Advertise
  • Lab Access
  • Lab Membership
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.